NIMH Chemical Synthesis and Drug Supply Program

Compound Information Page

Compound Name: N-(tert-Butyloxycarbonyl)-6-nitro-5-(trimethylstannyl)quipazine
NIMH Code: Q-707
Alternative Name:
Abbreviation:
Indications: radioiodinated 5-HT uptake inhibitor precursor
Package Sizes:
References: C. A. Mathis, J. D. Enas, S. M. Hanrahan and E. Akgun, Synthesis of 123I- and 125I-labelled 5-iodo-6-nitroquipazine, J. Labelled Cpd. Radiopharm., 34, 905-913 (1994); C. A. Mathis, A. Biegon, S. Taylor, J. Enas, S. Hanrahan and W. J. Jagust, [125I]5-Iodo-6-nitropquipazine: synthesis and evaluation of potent and selective presynaptic serontonin lignand, J. Nucl. Med., 33 (suppl), 890 (1992) (abstract from Proceedings of the 39th Annual Meeting of the Society of Nuclear Medicine, June 9-12, 1992).
CAS:
Molecular Formula: C21H30N4O4Sn
HBA: 6
HBD: 0
RotB: 5
PubChemID: 10484351
AlogP: 3.401
TPSA: 91.49
Activity:
Comments:
Last Updated 2008-11-11 02:58 PM
Structure of Q-707
About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».